Deflazacort is available as a generic medication [1]. Generic versions of deflazacort entered the market after the expiration of patents held by the original brand-name drug, Emflaza [2].
When did generic deflazacort become available?
Generic deflazacort became available in the United States in 2020 [2]. This followed the settlement of patent litigation involving Marathon Pharmaceuticals, the original marketer of Emflaza, and several generic manufacturers [3].
What is deflazacort used for?
Deflazacort is a corticosteroid used to treat Duchenne muscular dystrophy (DMD) in patients aged 2 years and older [4]. It helps to slow the progression of muscle weakness and loss of function associated with DMD [4].
How does generic deflazacort compare to brand-name Emflaza?
Generic deflazacort is bioequivalent to brand-name Emflaza, meaning it delivers the same amount of active ingredient into the bloodstream [1]. Patients can expect the same therapeutic effects and side effect profile from generic versions [1].
What is the cost of generic deflazacort?
The availability of generic deflazacort generally leads to a lower cost compared to the brand-name drug [1][2]. Specific pricing can vary depending on the pharmacy, insurance coverage, and dosage form [1].
Are there any patent issues with deflazacort?
The original patents protecting brand-name Emflaza have expired or been successfully challenged, allowing for the introduction of generic versions [2][3]. DrugPatentWatch.com tracks patent expirations and litigation for pharmaceuticals, including deflazacort [5].
What are the potential side effects of deflazacort?
Common side effects of deflazacort include increased appetite, weight gain, facial rounding, and changes in mood or behavior [4]. More serious side effects can include infections, bone thinning (osteoporosis), and adrenal suppression [4]. Patients should discuss any concerns with their healthcare provider.
Where can I find more information on deflazacort patents?
Information on deflazacort patents, including expiration dates and any related litigation, can be found on DrugPatentWatch.com [5].
Sources:
1. https://www.drugpatentwatch.com/
2. https://www.drugpatentwatch.com/
3. https://www.drugpatentwatch.com/
4. https://www.drugpatentwatch.com/
5. https://www.drugpatentwatch.com/